United States · FDA National Drug Code directory
Tadalafil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-581_21f23cde-ebd8-aa67-e063-6394a90a7150
- Product NDC
- 71610-581
- Form
- TABLET, FILM COATED
- Composition / generic term
- Tadalafil
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210121
- Source listing expiry
- 20261231
Source-listed ingredients
- TADALAFIL — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET, FILM COATED in 1 BOTTLE (71610-581-04) · 71610-581-04
- 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-581-06) · 71610-581-06
- 12 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-581-12) · 71610-581-12
- 1440 TABLET, FILM COATED in 1 BOTTLE (71610-581-39) · 71610-581-39
- 18 TABLET, FILM COATED in 1 BOTTLE (71610-581-52) · 71610-581-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →